Kristen Fortney, BioAge Labs CEO

Next-gen obe­si­ty biotech BioAge Labs to raise $198M in IPO

A Cal­i­for­nia biotech that be­gan as an an­ti-ag­ing com­pa­ny, then li­censed an Am­gen heart fail­ure drug for $1 mil­lion up­front and re­pur­posed it as a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA